Topotecan Terminated Phase 2 Trials for Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00194935Weekly Topotecan Therapy in Patients With Ovarian Cancer
NCT01003938Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer